Analysts have nudged up their fair value estimate for Ball Corporation, reflecting a delicate balance between improved operational execution and lingering concerns over mid-term demand. The adjustment highlights the evolving narrative around the packaging giant's competitive edge.
Walmart's fair value estimate sees a modest uptick, reflecting a nuanced analyst landscape where operational strength contends with broader retail sector headwinds.
Analysts have raised Genco Shipping & Trading's fair value estimate to $24.10 per share, signaling a belief that the dry bulk carrier's prospects extend beyond Diana Shipping's cash offer of $20.60 per share. The revision reflects adjusted assumptions on discount rates and revenue growth, setting the stage for a potential bidding war or strategic review.
Dollar General (DG) is witnessing a significant resurgence, driven by stronger-than-expected fourth-quarter performance marked by robust same-store sales and expanding margins. Investor optimism is reflected in a dramatic 90-day share price surge, though long-term returns tell a more complex story.
Albertsons Companies (ACI) shares present a compelling valuation puzzle. Trading at a significant discount to intrinsic value estimates, the grocery giant's stock appears cheap on paper. Yet, its performance lags behind peers, raising questions about whether the market is missing an opportunity or seeing risks that models overlook.
Gold prices stabilized near $4,950 an ounce after a sharp rebound, as bargain hunters moved in following last week's dramatic sell-off. Despite remaining below its late-January peak, the metal has posted strong gains for the year, with analysts debating the sustainability of the recovery amid elevated volatility.
Intapp's fiscal second-quarter results showcase robust growth driven by cloud migration and its vertical AI strategy, with cloud ARR surging 31%. The company highlights deepening partnerships with Microsoft and significant client wins across legal, accounting, and financial services sectors.
Enphase Energy posted a resilient fourth quarter, buoyed by U.S. demand ahead of a key tax credit deadline. While revenue hit $343.3M, margins faced pressure from tariffs and a softer European market. The company is betting on new battery and commercial products to drive growth as it forecasts a demand rebound later this year.
California wildlife officials have granted final approval for a ground-based operation to remove invasive mule deer from Catalina Island, a significant revision from earlier, widely criticized proposals involving helicopter sharpshooters.
While Novo Nordisk and Eli Lilly dominate the booming obesity drug market, clinical-stage biotech Viking Therapeutics is emerging as a speculative but potentially transformative investment for those willing to embrace risk.
House Speaker Mike Johnson (R-LA) has raised doubts about the integrity of three 2024 congressional elections, aligning with former President Trump's longstanding claims of systemic flaws, while advocating for stricter voting laws.
A Virginia state senator has introduced legislation that would formally define and criminalize Islamophobia as a hate crime in cases of assault and battery, aiming to address rising anti-Muslim prejudice.
Four Utah siblings, reported missing after Thanksgiving, have been located in a Dubrovnik orphanage and released to their father's custody. Their mother faces arrest in Croatia on child-related charges as the family begins its journey home.
Amdocs reported first-quarter revenue of $1.16B, meeting guidance, while highlighting strategic AI investments, European expansion, and the closure of its MATRIXX Software acquisition. The company also announced a planned CEO succession for March 2026.
eGain Corporation (EGAN) reported stronger-than-anticipated fiscal Q2 results, driven by accelerating adoption of its AI Knowledge Hub and a growing partner ecosystem. The company highlighted major enterprise wins and robust financial metrics, signaling a strategic shift towards AI-powered customer engagement.
Amgen reported robust 2025 results, driven by double-digit growth across its portfolio, and provided a confident outlook for 2026. While highlighting key growth drivers like Repatha and MariTide, the company also addressed portfolio pruning and an ongoing regulatory dialogue concerning Tavneos.
AMETEK (NYSE: AME) closed its fiscal 2025 with historic quarterly results, reporting double-digit growth across key metrics and a record $3.58 billion backlog. The diversified manufacturer also provided 2026 guidance projecting mid- to high-single-digit sales growth, signaling confidence in its operational momentum and strategic acquisition pipeline.
Specialty chemicals leader Ashland reports a mixed Q1 FY2026, with resilient performance in Life Sciences and Personal Care offsetting continued softness in coatings and construction. The company revises its full-year EBITDA guidance, citing operational delays at a key facility and weather-related disruptions.
Archer Daniels Midland reported mixed Q4 results, with profits pressured in its core Ag Services & Oilseeds unit. While management touted operational improvements and a strong cash flow performance, they cautioned that clarity on U.S. biofuel policy is key to unlocking a more constructive outlook for the year ahead.
With the Department of Education phasing out the SAVE repayment plan, millions of borrowers face a critical transition. This guide breaks down the available standard and income-driven plans to help navigate the shift and avoid financial pitfalls.
